Log In
Print this Print this

Lysodren, mitotane

  Manage Alerts
Collapse Summary General Information
Company HRA Pharma S.A.
DescriptionIsomer of dichlorodiphenyldichloroethane and derivative of dichlorodiphenyltrichloroethane
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard Indication Cancer (unspecified)
Indication DetailsTreat functional adrenal cortical carcinoma
Regulatory Designation EU - Orphan Drug (Treat functional adrenal cortical carcinoma)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today